RespireRx Pharmaceuticals Inc.RespireRx Pharmaceuticals Inc.RespireRx Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc.

No trades
See on Supercharts
Market capitalization
‪328.88 K‬USD
−0.0139USD
‪−2.10 M‬USD
‪341.18 M‬
Beta (1Y)
1.01

About RespireRx Pharmaceuticals Inc.

CEO
Arnold S. Lippa
Headquarters
Glen Rock
Employees (FY)
6
Founded
1987
FIGI
BBG000GRR1M6
RespireRx Pharmaceuticals, Inc. engages in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurological and psychiatric disorders. The company was founded by Carl W. Cotman, Wayne Pambianchi and Gary S. Lynch on February 10, 1987 and is headquartered in Glen Rock, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RSPI is 0.0009 USD — it has increased by 6.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange RespireRx Pharmaceuticals Inc. stocks are traded under the ticker RSPI.
RespireRx Pharmaceuticals Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
RSPI stock is 11.76% volatile and has beta coefficient of 1.01. Check out the list of the most volatile stocks — is RespireRx Pharmaceuticals Inc. there?
Yes, you can track RespireRx Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
RSPI stock has fallen by 15.00% compared to the previous week, the month change is a 5.56% fall, over the last year RespireRx Pharmaceuticals Inc. has showed a 69.64% decrease.
RSPI net income for the last quarter is ‪−395.50 K‬ USD, while the quarter before that showed ‪−681.03 K‬ USD of net income which accounts for 41.93% change. Track more RespireRx Pharmaceuticals Inc. financial stats to get the full picture.
Today RespireRx Pharmaceuticals Inc. has the market capitalization of ‪292.34 K‬, it has decreased by 10.00% over the last week.
No, RSPI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RSPI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RespireRx Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.
RSPI reached its all-time high on Jan 16, 1992 with the price of 76612.9875 USD, and its all-time low was 0.0006 USD and was reached on Oct 30, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 6.00 employees. See our rating of the largest employees — is RespireRx Pharmaceuticals Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RespireRx Pharmaceuticals Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RespireRx Pharmaceuticals Inc. stock shows the sell signal. See more of RespireRx Pharmaceuticals Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.